sales@angenesci.com
Login | Register
logo
Structures Search
Home Other Building Blocks 3-Pyridinecarboxamide, ar-(phenylmethyl)- (9CI)

3-Pyridinecarboxamide, ar-(phenylmethyl)- (9CI)

CAS No.:
1322-50-5
Catalog Number:
AG0010DA
Molecular Formula:
C13H12N2O
Molecular Weight:
212.2472
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
1 week
United States
$352
- +
5g
1 week
United States
$1270
- +
10g
1 week
United States
$2455
- +
25g
1 week
United States
$4891
- +
Product Description
Catalog Number:
AG0010DA
Chemical Name:
3-Pyridinecarboxamide, ar-(phenylmethyl)- (9CI)
CAS Number:
1322-50-5
Molecular Formula:
C13H12N2O
Molecular Weight:
212.2472
MDL Number:
MFCD00023577
IUPAC Name:
N-benzylpyridine-3-carboxamide
InChI:
InChI=1S/C13H12N2O/c16-13(12-7-4-8-14-10-12)15-9-11-5-2-1-3-6-11/h1-8,10H,9H2,(H,15,16)
InChI Key:
JIAOUYONZMRJJD-UHFFFAOYSA-N
SMILES:
O=C(c1cccnc1)NCc1ccccc1
EC Number:
219-705-1
UNII:
HF1W0213QP
NSC Number:
59992
Properties
Complexity:
224  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
212.095g/mol
Formal Charge:
0
Heavy Atom Count:
16  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
212.252g/mol
Monoisotopic Mass:
212.095g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
42A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.5  
Literature
Title Journal
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
Anticonvulsant and acute neurotoxic characteristics of nicotinic acid benzylamide: a preclinical study. Pharmacological reports : PR 20060101
Quinone reductase 2 substrate specificity and inhibition pharmacology. Chemico-biological interactions 20050210
Stability of two new anticonvulsants in body fluids and tissues. Acta poloniae pharmaceutica 20040101
Qualitative and quantitative analysis of three amino acid derivatives of anticonvulsant activity. Acta poloniae pharmaceutica 20030101
Properties